VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback